Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Petersdorf

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biotechnology (Reading, Mass.)|January 1, 1991
Hematopoietic colony-stimulating factorsK Kaushansky, C B Brown, S Petersdorf
Leukemia|April 9, 2016
Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first courseM Othus, S Mukherjee, M A Sekeres, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Bone Marrow Transplantation|July 15, 2003
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimenF Gutierrez-Delgado, L Holmberg, H Hooper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Samarium-153-EDTMP biodistribution and dosimetry estimationJ F Eary, C Collins, M Stabin, et al.
Bone Marrow Transplantation|November 1, 1994
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignanciesC H Weaver, W I Bensinger, F R Appelbaum, et al.
Leukemia|June 14, 2013
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD AndersonM Othus, H Kantarjian, S Petersdorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trialC Collins, J F Eary, G Donaldson, et al.
Bone Marrow Transplantation|March 1, 1997
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II studyN Robinson, M C Benyunes, J A Thompson, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biotechnology (Reading, Mass.)|January 1, 1991
Hematopoietic colony-stimulating factorsK Kaushansky, C B Brown, S Petersdorf
Leukemia|April 9, 2016
Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first courseM Othus, S Mukherjee, M A Sekeres, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Bone Marrow Transplantation|July 15, 2003
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimenF Gutierrez-Delgado, L Holmberg, H Hooper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Samarium-153-EDTMP biodistribution and dosimetry estimationJ F Eary, C Collins, M Stabin, et al.
Bone Marrow Transplantation|November 1, 1994
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignanciesC H Weaver, W I Bensinger, F R Appelbaum, et al.
Leukemia|June 14, 2013
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD AndersonM Othus, H Kantarjian, S Petersdorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trialC Collins, J F Eary, G Donaldson, et al.
Bone Marrow Transplantation|March 1, 1997
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II studyN Robinson, M C Benyunes, J A Thompson, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Pageof 2